Viridian Therapeutics Inc... (VRDN)
14.40
-1.13 (-7.28%)
At close: Mar 03, 2025, 3:59 PM
14.41
0.03%
After-hours: Mar 03, 2025, 04:54 PM EST
Viridian Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 102.83M | 155.58M | 42.3M | 45.9M | 24.85M | 32.61M | 47.44M | 3.34M | 10.83M | 5.12M | 209.35K | 112.53K |
| Short-Term Investments | 374.54M | 268.97M | 154.67M | 81.74M | 2M | 29.88M | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 604K | 7.61M | 1.49M | 857K | -523K | 50K | 50K | 258K | 15K | 90K | 690.05K | 45.58K |
| Receivables | 102K | 102K | 451K | n/a | 108K | 24K | 1.46M | 524K | 394K | 1.09M | 994.01K | 1.2M |
| Inventory | n/a | -6.62M | n/a | n/a | n/a | n/a | 1.00 | 64K | 187K | 179K | 356.64K | 169.54K |
| Other Current Assets | 9.01M | 6.52M | 2.65M | 1.97M | 5.38M | 5.23M | 4.84M | 330K | 642K | 399K | 495K | 185.84K |
| Total Current Assets | 486.48M | 424.55M | 200.16M | 129.61M | 29.74M | 65.37M | 51.87M | 4.26M | 11.73M | 6.79M | 2.05M | 1.66M |
| Property-Plant & Equipment | 3.34M | 2.94M | 2.06M | 787K | 523K | 727K | 563K | 625K | 1.15M | 1.21M | 928.03K | 1.07M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.95M | 10.54M | 3.55M | 1.64M | 523K | 777K | 613K | 883K | 1.17M | 1.3M | 1.62M | 1.12M |
| Total Assets | 490.42M | 435.09M | 203.71M | 131.25M | 30.26M | 66.15M | 52.48M | 4.26M | 12.9M | 8.09M | 3.67M | 2.78M |
| Account Payables | 2.24M | 14.23M | 2.33M | 670K | 1.1M | 571K | 906K | 159K | 242K | 255K | 100K | 26.66K |
| Deferred Revenue | 288K | 288K | 289K | 301K | 5.01M | 3.79M | n/a | 3.38M | 1.02M | n/a | 76.41K | 788.19K |
| Short-Term Debt | 843K | 613K | 520K | 455K | 3.98M | 2.29M | n/a | n/a | 1.1M | 80K | 697.06K | 22.59M |
| Other Current Liabilities | 23.27M | 18.21M | 10.5M | 9.25M | 5.11M | 3.87M | 2.99M | 4.43M | 1.12M | 1.65M | 513.31K | 988.19K |
| Total Current Liabilities | 26.64M | 33.35M | 13.64M | 10.67M | 10.18M | 6.73M | 3.9M | 4.58M | 2.47M | 1.99M | 1.39M | 23.6M |
| Long-Term Debt | 20.2M | 4.64M | n/a | n/a | 4.33M | 8M | 9.92M | 2.82M | n/a | n/a | n/a | 42.05K |
| Other Long-Term Liabilities | 989K | 1.17M | 1.21M | 544K | n/a | 66K | 152K | n/a | 24K | 109K | 259.35K | 578.8K |
| Total Long-Term Liabilities | 21.77M | 6.68M | 2.36M | 544K | 4.33M | 8.07M | 10.07M | 2.82M | 24K | 109K | 259.35K | 620.85K |
| Total Liabilities | 48.4M | 40.03M | 15.99M | 11.22M | 14.51M | 14.8M | 13.97M | 4.58M | 2.49M | 2.1M | 1.65M | 24.22M |
| Total Debt | 21.05M | 5.26M | 520K | 455K | 8.3M | 10.3M | 9.92M | 1.04M | 1.1M | 80K | 697.06K | 22.63M |
| Common Stock | 540K | 414K | 239K | 42K | 349K | 308K | 226K | 7K | 106K | 38K | 27.91K | n/a |
| Retained Earnings | -725.91M | -488.17M | -358.3M | -278.89M | -168.17M | -126.3M | -93.59M | -30.64M | -17.97M | -6.64M | -25.89M | -21.44M |
| Comprehensive Income | 338K | -390K | -157K | -8K | n/a | -3K | -2.83M | -0.00 | -739K | -555K | -411.05K | -262.74K |
| Shareholders Equity | 442.02M | 395.06M | 187.72M | 120.04M | 15.75M | 51.34M | 38.51M | -326K | 10.41M | 5.99M | 2.03M | -21.44M |
| Total Investments | 374.54M | 268.97M | 154.67M | 81.74M | 2M | 29.88M | n/a | n/a | n/a | n/a | n/a | n/a |